The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Celgene
Research Funding - Celgene (Inst)
Effect of olutasidenib (FT-2102) on complete remissions in patients with relapsed/refractory (R/R) mIDH1 acute myeloid leukemia (AML): Results from a planned interim analysis of a phase 2 clinical trial.
 
Stéphane De Botton
Consulting or Advisory Role - Abbvie; AGIOS; Astellas Pharma; Bayer; CELGENE; Daiichi Sankyo; FORMA Therapeutics; Janssen-Cilag; Pfizer; Seagen; Syros Pharmaceuticals
Speakers' Bureau - Abbvie; Astellas Pharma; Celgene; Daiichi Sankyo; Janssen-Cilag; Jazz Pharmaceuticals
Research Funding - Agios (Inst); FORMA Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Daiichi Sankyo; FORMA Therapeutics; Novartis; Pfizer; Seagen; Syros Pharmaceuticals
 
Karen W. L. Yee
Honoraria - Bristol-Myers Squibb/Celgene
Consulting or Advisory Role - Bristol-Myers Squibb; Pfizer; Roche; Taiho Pharmaceutical; Takeda
Research Funding - Astex Pharmaceuticals (Inst); FORMA Therapeutics (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Onconova Therapeutics (Inst); Roche/Genentech (Inst)
 
Christian Recher
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Astellas Pharma; Celgene; Daiichi Sankyo; Incyte; Janssen; Jazz Pharmaceuticals; Macrogenics; Novartis; Novartis; Otsuka; Pfizer; Roche; Takeda
Research Funding - Abbvie (Inst); Agios (Inst); Amgen (Inst); Astellas Pharma (Inst); Celgene (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); IQVIA (Inst); Jazz Pharmaceuticals (Inst); MaaT Pharma (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Celgene; Daiichi Sankyo; Gilead Sciences; Incyte; Novartis; Sanofi
 
Andrew Wei
Honoraria - Abbvie/Genentech; Amgen; Astellas Pharma; AstraZeneca; Celgene; Janssen Oncology; Macrogenics; Novartis; Pfizer; SERVIER
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Astellas Pharma; AstraZeneca; Celgene; Janssen; Macrogenics; Novartis; Pfizer; SERVIER
Speakers' Bureau - Abbvie/Genentech; Celgene/Bristol-Myers Squibb; Novartis
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Roche (Inst); Servier (Inst)
Patents, Royalties, Other Intellectual Property - AW is a former employee of the Walter and Eliza Hall Institute which receives milestone and royalty payments related to venetoclax, and is eligible for benefits related to these payments. AW receives payments from WEHI related to venetoclax
 
Pau Montesinos
Consulting or Advisory Role - Abbvie; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Roche; Shire
Speakers' Bureau - Celgene; Daiichi Sankyo; Otsuka
Research Funding - Celgene (Inst); Janssen-Cilag (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen
 
David Taussig
Research Funding - Bayer; Celgene
Travel, Accommodations, Expenses - Abbvie
 
Arnaud Pigneux
Consulting or Advisory Role - Abbvie; Abbvie; AMGEN; Astellas Pharma; DAICHI; Jazz Pharmaceuticals; Pfizer; Roche
Travel, Accommodations, Expenses - Sanofi
 
Thorsten Braun
Honoraria - Daiichi Sankyo
Research Funding - SERVIER
 
Antonio Curti
No Relationships to Disclose
 
Jordi Esteve
Consulting or Advisory Role - Abbvie; Astellas Pharma; Celgene; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Roche
 
Carolyn Grove
Honoraria - Astellas Pharma (Inst)
Consulting or Advisory Role - Astellas Pharma
 
Brian Andrew Jonas
Consulting or Advisory Role - Abbvie; Genentech; GlycoMimetics; Jazz Pharmaceuticals; Takeda; Tolero Pharmaceuticals; Treadwell Therapeutics
Research Funding - Abbvie (Inst); Accelerated Medical Diagnostics (Inst); Amgen (Inst); Arog (Inst); Celgene (Inst); Daiichi Sankyo (Inst); FORMA Therapeutics (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Glycomimetics (Inst); Hanmi (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); LP Therapeutics (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst); Sigma-Tau (Inst)
Travel, Accommodations, Expenses - Abbvie
 
Asim Khwaja
Consulting or Advisory Role - Astellas Pharma; Jazz Pharmaceuticals
Speakers' Bureau - Jazz Pharmaceuticals; Novartis
 
Ollivier Legrand
No Relationships to Disclose
 
Pierre Peterlin
No Relationships to Disclose
 
Olga Polyanskaya
Employment - Forma Therapeutics
 
Jennifer Sweeney
Employment - Forma Therapeutics
 
Hesham Mohamed
Employment - Forma Therapeutics
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; Astellas Pharma; Bio-Path Holdings, Inc; BiolineRx; Bristol-Myers Squibb; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Takeda
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Immunogen (Inst); Jazz Pharmaceuticals (Inst); Merus (Inst); Novartis (Inst); Pfizer (Inst); Sun Pharma (Inst); Takeda (Inst); Tolero Pharmaceuticals (Inst); Trovagene (Inst)
 
Pierre Fenaux
No Relationships to Disclose